Request for Covid-19 Impact Assessment of this Report

Take Action
Healthcare

Global Women’s Health Diagnostics Market Size study, by Application (Prenatal Testing, Down Syndrome, Fertility Test, Pregnancy Test, Urinary Tract Infections, Osteoporosis, Breast, Cervical, Ovarian Cancer Test), by End User (Hospitals, Home care) and Regional Forecasts 2019-2026

  • BIZ3460425
  • 200 Pages
  • January 2020
  • Healthcare
Download Sample    Get Discount   
 
Global Women’s Health Diagnostics Market is valued approximately USD 28 billion in 2018 and is anticipated to grow with a healthy growth rate of more than 7.9% over the forecast period 2019-2026. Women are more susceptible to certain diseases, usually related to depression, osteoporosis, menstrual disorders, obesity, and autoimmune diseases. Women's major health concerns are associated with the procreative system that incorporates polycystic ovarian syndrome, infertility, menopause and cancers such as cervical cancer, breast cancer, and urological disorders. As per the, National Institute of Health (NIH), about 40% of women deals with at least one UTI (urinary tract infection) in their lifetime. Further, as per the source, women are 30 times more likely than men to develop a UTI under the age of 50. Moreover, according to the study conducted by University of Chicago (2018), the rate of urinary incontinence is more in 60 & above-aged females which are estimated approximately 69% globally due to geriatric syndrome with age-related changes in physiology, comorbidity, medications and especially functional impairments. High incidence of infectious diseases in women coupled with rising number of chronic and lifestyle-related syndromes in women is increasing the adoption of diagnostics imaging procedures. These women’s health diagnostic tests involve various tests such as pregnancy and ovulation tests, breast cancer tests, ovarian cancer tests, and others. Thus, increasing number of women’s health related disorder is driving the market. Furthermore, improving healthcare infrastructure in emerging markets and growing number of regulatory approvals for immunoassay diagnostic techniques is expected to create significant growth opportunity in the market over the forecast period. However, lack of a skilled workforce coupled with high cost of diagnostic imaging systems impedes the growth of the market over the forecast period of 2019-2026.

The regional analysis of global Women’s Health Diagnostics market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading/significant region across the world in terms of market share owing to the increasing prevalence of cancer among women coupled with the increasing incidences of lifestyle-oriented health disorders. Whereas, Asia-Pacific is also anticipated to exhibit highest growth rate / CAGR over the forecast period 2019-2026. Factors such as rising awareness about women’s health disorder, government initiative and improving healthcare infrastructure would create lucrative growth prospects for the Women’s Health Diagnostics market across Asia-Pacific region.

Major market player included in this report are:

Siemens AG

Quest Diagnostics Inc.

Hologic, Inc.

F. Hoffmann-La Roche AG

Perkinelmer Inc.

Alere Inc.

GE Healthcare

Becton, Dickinson and Company

Abbott Laboratories

Biomérieux SA

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Application:

Prenatal Testing,

Down Syndrome

Fertility Test Pregnancy Test,

Urinary Tract Infections,

Osteoporosis,

Breast cancer testing

Cervical cancer testing

Ovarian Cancer Test

By End User:

Hospitals

Home care

By Region:

North America

U.S.

Canada

Europe

UK

Germany

Asia Pacific

China

India

Japan

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2016, 2017

Base year – 2018

Forecast period – 2019 to 2026

Target Audience of the Global Women’s Health Diagnostics Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Chapter 1. Executive Summary

1.1. Market Snapshot

1.2. Global & Segmental Market Estimates & Forecasts, 2017-2026 (USD Billion)

1.2.1. Women’s Health Diagnostics Market, by Region, 2017-2026 (USD Billion)

1.2.2. Women’s Health Diagnostics Market, by Application, 2017-2026 (USD Billion)

1.2.3. Women’s Health Diagnostics Market, by End- User, 2017-2026 (USD Billion)

1.3. Key Trends

1.4. Estimation Methodology

1.5. Research Assumption

Chapter 2. Global Women’s Health Diagnostics Market Definition and Scope

2.1. Objective of the Study

2.2. Market Definition & Scope

2.2.1. Scope of the Study

2.2.2. Industry Evolution

2.3. Years Considered for the Study

2.4. Currency Conversion Rates

Chapter 3. Global Women’s Health Diagnostics Market Dynamics

3.1. Women’s Health Diagnostics Market Impact Analysis (2018-2026)

3.1.1. Market Drivers

3.1.2. Market Challenges

3.1.3. Market Opportunities

Chapter 4. Global Women’s Health Diagnostics Market Industry Analysis

4.1. Porter’s 5 Force Model

4.1.1. Bargaining Power of Suppliers

4.1.2. Bargaining Power of Buyers

4.1.3. Threat of New Entrants

4.1.4. Threat of Substitutes

4.1.5. Competitive Rivalry

4.1.6. Futuristic Approach to Porter’s 5 Force Model (2016-2026)

4.2. PEST Analysis

4.2.1. Political

4.2.2. Economical

4.2.3. Social

4.2.4. Technological

4.3. Investment Adoption Model

4.4. Analyst Recommendation & Conclusion

Chapter 5. Global Women’s Health Diagnostics Market, by Application

5.1. Market Snapshot

5.2. Global Women’s Health Diagnostics Market by Application, Performance - Potential Analysis

5.3. Global Women’s Health Diagnostics Market Estimates & Forecasts by Application 2016-2026 (USD Billion)

5.4. Women’s Health Diagnostics Market, Sub Segment Analysis

5.4.1. Prenatal Testing

5.4.2. Down Syndrome

5.4.3. Fertility Test

5.4.4. Pregnancy Test

5.4.5. Urinary Tract Infections

5.4.6. Osteoporosis

5.4.7. Breast cancer testing

5.4.8. Cervical cancer testing

5.4.9. Ovarian Cancer Test

Chapter 6. Global Women’s Health Diagnostics Market, by End -User

6.1. Market Snapshot

6.2. Global Women’s Health Diagnostics Market by End User, Performance - Potential Analysis

6.3. Global Women’s Health Diagnostics Market Estimates & Forecasts by End User 2016-2026 (USD Billion)

6.4. Women’s Health Diagnostics Market, Sub Segment Analysis

6.4.1. Hospital

6.4.2. Home care

Chapter 7. Global Women’s Health Diagnostics Market, Regional Analysis

7.1. Women’s Health Diagnostics Market, Regional Market Snapshot

7.2. North America Women’s Health Diagnostics Market

7.2.1. U.S. Women’s Health Diagnostics Market

7.2.1.1. Application breakdown estimates & forecasts, 2016-2026

7.2.1.2. End- User breakdown estimates & forecasts, 2016-2026

7.2.2. Canada Women’s Health Diagnostics Market

7.3. Europe Women’s Health Diagnostics Market Snapshot

7.3.1. U.K. Women’s Health Diagnostics Market

7.3.2. Germany Women’s Health Diagnostics Market

7.3.3. Rest of Europe Women’s Health Diagnostics Market

7.4. Asia-Pacific Women’s Health Diagnostics Market Snapshot

7.4.1. China Women’s Health Diagnostics Market

7.4.2. India Women’s Health Diagnostics Market

7.4.3. Japan Women’s Health Diagnostics Market

7.4.4. Rest of Asia Pacific Women’s Health Diagnostics Market

7.5. Latin America Women’s Health Diagnostics Market Snapshot

7.5.1. Brazil Women’s Health Diagnostics Market

7.5.2. Mexico Women’s Health Diagnostics Market

7.6. Rest of The World Women’s Health Diagnostics Market

Chapter 8. Competitive Intelligence

8.1. Top Market Strategies

8.2. Company Profiles

8.2.1. Siemens AG

8.2.1.1. Key Information

8.2.1.2. Overview

8.2.1.3. Financial (Subject to Data Availability)

8.2.1.4. Product Summary

8.2.1.5. Recent Developments

8.2.2. Quest Diagnostics Inc.

8.2.3. Hologic, Inc.

8.2.4. F. Hoffmann-La Roche AG

8.2.5. Perkinelmer Inc.

8.2.6. Alere Inc.

8.2.7. GE Healthcare

8.2.8. Becton, Dickinson and Company

8.2.9. Abbott Laboratories

8.2.10. Biomérieux SA

Chapter 9. Research Process

9.1. Research Process

9.1.1. Data Mining

9.1.2. Analysis

9.1.3. Market Estimation

9.1.4. Validation

9.1.5. Publishing

9.2. Research Attributes

9.3. Research Assumption

List of Tables

TABLE 1. LIST OF SECONDARY SOURCES, USED IN THE STUDY OF GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET

TABLE 2. LIST OF PRIMARY SOURCES, USED IN THE STUDY OF GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET

TABLE 3. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET, REPORT SCOPE

TABLE 4. YEARS CONSIDERED FOR THE STUDY

TABLE 5. EXCHANGE RATES CONSIDERED

TABLE 6. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY REGION 2016-2026 (USD BILLION)

TABLE 7. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY APPLICATION 2016-2026 (USD BILLION)

TABLE 8. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY END- USER 2016-2026 (USD BILLION)

TABLE 9. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 10. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 11. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 12. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 13. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 14. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 15. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 16. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 17. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 18. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 19. U.S. WOMEN’S HEALTH DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 20. U.S. WOMEN’S HEALTH DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 21. U.S. WOMEN’S HEALTH DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 22. CANADA WOMEN’S HEALTH DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 23. CANADA WOMEN’S HEALTH DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 24. CANADA WOMEN’S HEALTH DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 25. UK WOMEN’S HEALTH DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 26. UK WOMEN’S HEALTH DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 27. UK WOMEN’S HEALTH DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 28. GERMANY WOMEN’S HEALTH DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 29. GERMANY WOMEN’S HEALTH DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 30. GERMANY WOMEN’S HEALTH DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 31. ROE WOMEN’S HEALTH DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 32. ROE WOMEN’S HEALTH DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 33. ROE WOMEN’S HEALTH DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 34. CHINA WOMEN’S HEALTH DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 35. CHINA WOMEN’S HEALTH DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 36. CHINA WOMEN’S HEALTH DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 37. INDIA WOMEN’S HEALTH DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 38. INDIA WOMEN’S HEALTH DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 39. INDIA WOMEN’S HEALTH DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 40. JAPAN WOMEN’S HEALTH DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 41. JAPAN WOMEN’S HEALTH DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 42. JAPAN WOMEN’S HEALTH DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 43. ROAPAC WOMEN’S HEALTH DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 44. ROAPAC WOMEN’S HEALTH DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 45. ROAPAC WOMEN’S HEALTH DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 46. BRAZIL WOMEN’S HEALTH DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 47. BRAZIL WOMEN’S HEALTH DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 48. BRAZIL WOMEN’S HEALTH DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 49. MEXICO WOMEN’S HEALTH DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 50. MEXICO WOMEN’S HEALTH DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 51. MEXICO WOMEN’S HEALTH DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 52. ROLA WOMEN’S HEALTH DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 53. ROLA WOMEN’S HEALTH DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 54. ROLA WOMEN’S HEALTH DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 55. ROW WOMEN’S HEALTH DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 56. ROW WOMEN’S HEALTH DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 57. ROW WOMEN’S HEALTH DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

2020 World Blood Typing, Grouping and Infectious Disease NAT Screening Market in 68 Countries: Supplier Shares and Strategies, Volume and Sales Segment Forecasts for over 40 Tests, Technology and Instrumentation Review

This new 68-country report from LeadingMarketResearch.com is available by region, country, market segment, section, or individual test.

The report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global blood banking market during the next five years, and assist industry executives in developing effective business, new ...

  • Publish Date: March 2, 2020
  • $0
View Details
Hearing Aids Market in India 2011

Hearing aids in the form of analog units have been traditionally present and used in India. Digital hearing units are finding increased growth in acceptability owing to the changing perceptions and growing base of the target consumer group. The Indian market is largely dependent on imports from foreign countries; domestic players in the country are ramping up their manufacturing facilities. The gr...

  • Publish Date: March 10, 2011
  • $950
View Details
Cardiac Pacemaker Market in India 2011

The Indian medical devices market is largely dependent on imports from foreign countries. Although domestic players in the country are ramping up their manufacturing facilities, the foreign companies continue to enjoy a superior market share on account of their brand recognition, reliability, and technological superiority. The growing target base of consumers will boost sales and the market is exp...

  • Publish Date: July 18, 2011
  • $950
View Details
 
View More
 

Client Testimonials

2026 © Copyright Big Market Research